Target intelligence / Profile preview

NOD-like receptor pyrin domain-containing protein 3 (NLRP3)

Target
NLRP3
Molecular classification
Pattern-recognition receptor (PRR), NOD-like receptor (NLR) family, Inflammasome sensor protein
01

Overview

NOD-like receptor pyrin domain-containing protein 3 (NLRP3) is a cytosolic pattern-recognition receptor that forms the core of the NLRP3 inflammasome, a multiprotein signaling platform in innate immune cells (predominantly macrophages). It senses a broad range of danger signals (PAMPs and DAMPs), leading to recruitment of adaptor protein ASC and pro-caspase-1, resulting in activation of caspase-1. This leads to maturation and secretion of the cytokines IL-1β and IL-18, and can trigger pyroptosis. When dysregulated, NLRP3 contributes to various inflammatory and autoimmune diseases, as well as some metabolic, neurodegenerative, and cardiovascular conditions. NLRP3 is actively investigated as a drug target, but specific inhibitors are mostly in preclinical or clinical trial stages. The query’s name "NOD-like receptor heat protein domain-related protein 3" is inaccurate and not standard in scientific literature. The universally acknowledged and biomedically relevant target is "NOD-like receptor pyrin domain-containing protein 3" (NLRP3).

Other names
NACHT, LRR, and PYD domains-containing protein 3 (NALP3)CryopyrinCold-induced autoinflammatory syndrome 1 (CIAS1)PYRIN-containing APAF1-like protein 1 (PYPAF1)Caterpillar-like receptor 1.1 (CLR1.1)
02

Mechanism of action

Direct inhibitors block NLRP3 activation/oligomerization. Drugs targeting NLRP3 prevent inflammasome assembly, caspase-1 activation, and subsequent release of IL-1β and IL-18.

03

Biological functions

Innate immune responseSensing pathogen-associated and damage-associated molecular patterns (PAMPs, DAMPs)Inflammation signalingActivation of caspase-1Maturation of pro-inflammatory cytokines (like IL-1β and IL-18)Regulation of pyroptosis (inflammatory cell death)
04

Disease associations

Autoinflammatory diseasesInflammationCardiovascular disease (e.g., atherosclerosis)Metabolic disorders (e.g., type 2 diabetes)Neurodegenerative diseases (e.g., Alzheimer’s disease, Parkinson’s disease)GoutInfections (role in host response)
05

Safety considerations

Blocking NLRP3 may increase susceptibility to infections (due to dampened innate immunity)Systemic immunosuppression or impairment of normal inflammatory/host defense responses
06

Interacting drugs

MCC950 (NLRP3 inhibitor)

1 more in the full profile.

07

Biomarkers

Elevated IL-1β or IL-18 levels (reflect inflammasome activity)NLRP3 protein expression in tissues or blood (research/clinical context)Caspase-1 activity (downstream indicator)

Beyond the preview

Go deeper on NOD-like receptor pyrin domain-containing protein 3 (NLRP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NOD-like receptor pyrin domain-containing protein 3 (NLRP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call